Penserra Capital Management LLC Coherus Bio Sciences, Inc. Transaction History

Penserra Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$15.81 - $18.99 $27,667 - $33,232	-1,750 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $317 - $444	25 Added 1.45%	1,750 $28,000
Q2 2021 Aug 12, 2021	BUY	$12.95 - $15.41 $906 - $1,078	70 Added 4.23%	1,725 $23,000
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $17,305 - $19,792	1,045 Added 171.31%	1,655 $28,000
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $10,620 - $12,132	610 New	610 $11,000
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $289,971 - $379,467	-17,757 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$16.3 - $23.37 $289,439 - $414,981	17,757 New	17,757 $359,000

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $80.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.